Orphan designation: Davunetide Treatment of activity-dependent neuroprotective protein (ADNP) syndrome, 13/12/2024 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 13 January 2025 - 15:08

Orphan designation: Davunetide Treatment of activity-dependent neuroprotective protein (ADNP) syndrome, 13/12/2024 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-3007

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters